CRA Site Monitoring Report Builder
Convert monitoring observations into FDA-compliant site reports with risk grading
What You Can Do
You can take unstructured monitoring visit observations and convert them into formal, audit-ready reports that categorize findings by risk level (Critical, Major, Minor), validate protocol compliance, and generate actionable follow-up items with assigned owners and resolution dates. The skill ensures your documentation meets FDA inspection standards and ICH-GCP requirements while creating clear escalation pathways for high-risk issues.
Features
automatically organizes observations into standardized sections (attendance, enrollment, safety review, data quality, protocol deviations, documentation)
categorizes issues as Critical, Major, or Minor with justification and escalation flags
applies ICH-GCP terminology and FDA inspection standard compliance checks
generates actionable items with assigned owners, target dates, and status monitoring
identifies patterns and systemic compliance issues across multiple visits
captures deviation details, root cause analysis, and remediation plans
ensures traceability and documentation sufficiency for regulatory inspections
links adverse events to protocol compliance and monitoring findings
Example Output
Input: Raw notes from site visit including "Patient #23 enrolled 2 weeks late, source data shows dose adjustment not documented, pharmacy inventory variance of 12 units"
Output:
FINDING #1: PROTOCOL DEVIATION — Late Patient Enrollment
Risk Level: MAJOR
Details: Patient #23 enrolled 12 days past protocol-specified window
Regulatory Impact: ICH-GCP 4.8.1 non-compliance
Action Items:
- Sponsor review and patient eligibility assessment (Owner: Dr. Smith, Due: 5 days)
- Amend informed consent if necessary (Owner: Site PI, Due: 10 days)
FINDING #2: DATA INTEGRITY ISSUE — Undocumented Dose Adjustment
Risk Level: CRITICAL
Details: Source documents lack supporting documentation for dose change on [DATE]
Escalation: Immediate sponsor and regulatory notification required
Action Items:
- Retrieve and scan source documents (Owner: Site Coordinator, Due: 2 days)
- Submit corrective action plan (Owner: Sponsor QA, Due: 5 days)
What's Included
- SKILL.md instruction file with skill configuration and usage guidelines:
- Monitoring Report Template: standardized structure for all report sections
- Risk Grading Rubric: criteria for Critical/Major/Minor categorization with FDA alignment
- ICH-GCP Compliance Checklist: validation points for regulatory standards
- Follow-up Action Tracker: template with owner assignment, priority matrix, and status fields
- Site Comparison Framework: multi-visit pattern analysis template
Who It's For
- Clinical Research Associates (CRAs) — conducting site monitoring visits and reporting findings
- Site Monitors — managing multiple trial sites and standardizing documentation
- Clinical Trial Project Managers — aggregating site data and identifying escalation needs
- Regulatory Affairs Specialists — reviewing monitoring reports for FDA compliance
- Quality Assurance teams — auditing site documentation and compliance records
Best For
- Converting raw monitoring visit notes into formal regulatory-compliant reports
- Risk-grading protocol deviations and safety findings for escalation
- Documenting adverse events and protocol compliance issues with audit trail completeness
- Generating corrective action plans and follow-up item tracking
- Preparing site documentation for FDA inspections and regulatory audits
- Identifying systemic compliance patterns across multiple clinical trial sites
You might also like
You can validate eCRF and paper CRF datasets against protocol-defined rules, automatically identify data discrepancies (missing fields, out-of-range values, date inconsistencies), generate structured Data Query Forms (DQFs) for site clarification, track resolution status, and create audit-ready compliance documentation that meets FDA 21 CFR Part 11 and GCP requirements. This workflow reduces manual validation time while ensuring 100% traceability and regulatory readiness for inspections.
by kody-w
You can design and execute bioanalytical method validations aligned with FDA Guidance for Industry and ICH guidelines, interpret complex validation data against regulatory acceptance criteria, and systematically troubleshoot analytical failures to identify root causes and corrective actions. This skill accelerates validation timelines by 20–30%, minimizes regulatory rework, and provides structured decision trees for problems that typically require expert consultation.
by kody-w
You can architect end-to-end bioinformatics analysis pipelines by translating your research question into algorithmic approaches, selecting and optimizing appropriate tools and parameters for your dataset, and validating results against biological expectations. This skill guides you through the complete decision tree from raw data to publication-ready interpretation, helping you avoid parameter overfitting, misinterpreted statistical thresholds, and algorithm selection errors that compromise research validity.
by kody-w
You consolidate parallel data streams from preclinical toxicology studies (clinical pathology, histopathology, body weight changes, organ weights, clinical observations, mortality) into coherent regulatory-compliant narratives. This skill synthesizes findings across 6–12 endpoints simultaneously, identifies NOAEL/LOAEL with biological justification, determines safety margins, interprets species-specific or sex-specific signals, and produces Results & Discussion sections that satisfy FDA/EMA reviewers while supporting appropriate dosing decisions for IND-enabling studies.
by kody-wClaude reviews your injection mold, stamping die, or precision tool designs for manufacturability, cost reduction opportunities, and tolerance optimization. You provide CAD specifications, material details, and production volume—Claude identifies specific design modifications, material alternatives, and tolerance adjustments that reduce tooling complexity and unit costs without compromising performance.
by kody-w
This skill helps you synthesize complex environmental toxicology and fate data into cohesive, regulatory-quality Environmental Assessment narratives. You can organize hazard identification, exposure assessment, and risk characterization frameworks; integrate multi-study ecotoxicity evidence; cross-reference FDA/EMA/ICH M7 guidance; and identify data gaps—all while maintaining scientific rigor and compliance consistency required for NDAs, INDs, and BPCIs.
by kody-w
This skill organizes complex toxicology datasets, clinical adverse events, and mechanistic findings into structured, FDA/EMA-compliant safety narratives. You input raw safety data—adverse event summaries, laboratory results, animal study findings, vital signs—and receive draft safety summaries, detailed safety assessments, and expedited safety reports ready for regulatory submission. It handles IND applications, annual safety updates, clinical development safety overviews, and urgent safety communications with proper MedDRA coding and regulatory formatting.
by kody-w
You can design experiments with appropriate controls, replicate structures, and sample sizes before conducting any bench work. This skill helps you establish clear endpoints, identify confounding variables, select the right statistical tests, and create reproducible data collection protocols—preventing costly failed experiments and increasing publishability.
by kody-w